Related Experiment Video
Updated: May 20, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2
Xiaodan Hu1, Jianchen Wu1, Lu Shi2
1New Cornerstone Science Laboratory, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
Abstract:
Microglial intrinsic immune checkpoints are essential safeguards to maintain immune homeostasis by preventing microglial overactivation, a process that substantially influences neurological disorders such as autism spectrum disorder (ASD). MEF2C is a crucial immune checkpoint that regulates microglial activation, but the mechanism remains unclear. We found that MEF2C-deficient (MEF2C-/-) induced microglia-like cells (iMGLs) derived from human pluripotent stem cells (hPSCs) exhibited overactivation following lipopolysaccharide stimulation, mimicking patterns observed in various neuroinflammatory disorders. High-throughput screening identified BMS265246, a cyclin-dependent kinase 2 (CDK2) inhibitor, which suppressed overactivation of MEF2C-/- iMGLs and normalized their inflammatory responses. Mechanistically, MEF2C transcriptionally upregulated p21 to inhibit CDK2 activation-mediated retinoblastoma protein (RB) degradation, thereby preventing transcription factor nuclear factor κB (NFκB) nuclear translocation and consequent microglial overactivation. BMS265246 treatment substantially ameliorated microglial overactivation and ASD-like behaviors in Mef2c-deficient mice. Our findings identify the MEF2C-p21-CDK2-RB-NFκB axis as a critical pathway to maintain microglial homeostasis and highlight CDK2 as a potential therapeutic target for neuroinflammation.
Insights
Microglial immune checkpoints prevent overactivation in neurological disorders. MEF2C loss causes overactivation, but CDK2 inhibition with BMS265246 restores homeostasis, offering a therapeutic target for neuroinflammation.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglial immune checkpoints are vital for preventing overactivation and maintaining immune homeostasis.
- Microglial overactivation is implicated in neurological disorders, including autism spectrum disorder (ASD).
- MEF2C is a key immune checkpoint regulating microglial activation, but its precise mechanism is not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which MEF2C regulates microglial activation.
- To identify potential therapeutic targets for microglial overactivation in neuroinflammatory conditions.
Main Methods:
- Utilized human pluripotent stem cell-derived microglia-like cells (iMGLs) from MEF2C-deficient (MEF2C-/-) and wild-type backgrounds.
- Performed high-throughput screening to identify compounds that suppress microglial overactivation.
- Investigated the molecular pathway involving MEF2C, p21, CDK2, RB, and NFκB.
- Assessed the efficacy of a CDK2 inhibitor (BMS265246) in vitro and in Mef2c-deficient mouse models.
Main Results:
- MEF2C-/- iMGLs exhibited overactivation upon lipopolysaccharide stimulation.
- BMS265246, a CDK2 inhibitor, suppressed MEF2C-/- iMGL overactivation and normalized inflammatory responses.
- MEF2C upregulates p21, which inhibits CDK2-mediated RB degradation, preventing NFκB nuclear translocation and microglial overactivation.
- BMS265246 treatment ameliorated microglial overactivation and ASD-like behaviors in Mef2c-deficient mice.
Conclusions:
- The MEF2C-p21-CDK2-RB-NFκB axis is critical for maintaining microglial homeostasis.
- CDK2 inhibition represents a promising therapeutic strategy for neuroinflammation and associated neurological disorders.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
MAPK Signaling Cascades
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

